A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Biological Activity, and PK of ND L02 s0201 in Subjects with Idiopathic Pulmonary Fibrosis (IPF)

Project: Research project

Project Details

Description

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Biological Activity, and PK of ND L02 s0201 in Subjects with Idiopathic Pulmonary Fibrosis (IPF)
StatusActive
Effective start/end date10/2/181/1/22

Funding

  • NITTO DENKO TECH CORP

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.